Abemaciclib metabolite M18

M18 (LSN3106729), an active metabolite of abemaciclib, is a potent CDK4/6 inhibitor. It has been utilized as a warhead in the design of CRBN-based PROTAC molecules, enabling targeted degradation of CDK4/6 proteins for research in oncology and cellular proliferation studies.